What Could You Expect from the 7th RNAi-Based Therapeutics Summit?
As landmark approvals in hemophilia and a flurry of billion-dollar partnerships for neurology and metabolic diseases validate RNAi's platform potential, the 7th RNAi-Based Therapeutics Summit was the industry’s definitive forum to translate these clinical and business successes into actionable development strategies that conquer extrahepatic delivery.
Through 30+ expert-led sessions, attendees explored how pioneers are moving beyond the liver to unlock new disease frontiers:
Join discovery to clinical development teams from the top pharma and biotechs to de-risk your path to the clinic and accelerate your extrahepatic pipeline in 2027.
2026 Event Highlights
Pre-Conference Workshops:
Master the chemical engineering of RNAi constructs to enhance stability and extrahepatic delivery and harness AI-powered in silico tools for target discovery and lead candidate optimization, bridging the gap between preclinical promise and clinical success.
Industry-Dedicated Networking:
Connect with leading RNAi companies through over 8+ hours of networking opportunities, including a dedicated Speed Networking session to get face-to-face time with key opinion leaders and innovative researchers in the field.
Novel RNAi Applications:
Discover novel applications of RNAi for oncology and anti-ageing by using multi-target cocktails and tumour-homing delivery systems to disrupt multiple disease pathways and overcome treatment resistance.
Engineering Next Gen Brain Delivery:
Overcome the final frontier of extrahepatic delivery in the CNS through Trojan horse formulations by leveraging receptor mediated transcytosis to demonstrate preclinical efficacy.
2026 Core Themes
Extrahepatic Delivery Breakthroughs:
Actionable strategies for targeted RNAi delivery to CNS, muscle, adipose, and cardiac tissue, moving beyond the liver to tackle neurology, metabolic disease, and fibrosis.
Clinical & CMC Roadmaps:
Exclusive data and development pathways from Alnylam, AbbVie, and pioneering biotechs on navigating complex synthesis, regulatory hurdles, and late-stage clinical development.
Next-Generation Modalities:
Explore cutting-edge platforms including antibody-oligonucleotide conjugates (AOCs), DNA origami, self-assembling nanostructures, and multi-targeting siRNA/miRNA approaches.
Investor & Industry Outlook:
Critical insights from top VCs and a cross-section of industry leaders on valuation drivers, partnership strategies, and future-proofing RNAi pipelines in a competitive landscape.
Explore the 2026 Event Guide
- 25+ expert speakers from pioneering biotechs and large pharma, including Sanegene Bio, AbbVie, Judo Bio, and more, sharing exclusive data and case studies.
- Actionable insights to conquer extrahepatic delivery for CNS, muscle, and cardiac tissues with novel strategies like aptamers, bispecifics, and exosomes.
- Dedicated deep-dives on the hottest applications: from obesity and metabolic disease to neurology, oncology, and more.
- Critical regulatory and CMC strategies to overcome complex synthesis, scale-up, and IND-enabling hurdles for late-stage clinical success.
Attending Companies Included
Explore the Agenda
Hear the latest industry breakthroughs and gain exclusive insights during our packed agenda, interactive roundtables, and panel discussions.
Partner With Us
Position yourself alongside other leading solution providers to ensure your brand is at the heart of biopharma deals.
Join Biopharma Experts
Be part of the hottest conversations with like-minded attendees spanning all stages of drug development and make critical connections during our dedicated networking sessions.